For: | Sasaki R, Kanda T, Nakamoto S, Haga Y, Nakamura M, Yasui S, Jiang X, Wu S, Arai M, Yokosuka O. Natural interferon-beta treatment for patients with chronic hepatitis C in Japan. World J Hepatol 2015; 7(8): 1125-1132 [PMID: 26052401 DOI: 10.4254/wjh.v7.i8.1125] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v7/i8/1125.htm |
Number | Citing Articles |
1 |
Reina Sasaki, Tatsuo Kanda, Shin Yasui, Yuki Haga, Masato Nakamura, Mutsumi Yamato, Shuang Wu, Shingo Nakamoto, Makoto Arai, Shigeru Mikami, Hideaki Miyauchi, Hisahiro Matsubara, Osamu Yokosuka. Successful Eradication of Hepatitis C Virus by Interferon-Free Regimens in Two Patients with Advanced Liver Fibrosis following Kidney Transplantation. Case Reports in Gastroenterology 2016; 10(2): 248 doi: 10.1159/000445374
|
2 |
Alexey S. Kazakov, Alexander D. Sofin, Nadezhda V. Avkhacheva, Alexander I. Denesyuk, Evgenia I. Deryusheva, Victoria A. Rastrygina, Andrey S. Sokolov, Maria E. Permyakova, Ekaterina A. Litus, Vladimir N. Uversky, Eugene A. Permyakov, Sergei E. Permyakov. Interferon Beta Activity Is Modulated via Binding of Specific S100 Proteins. International Journal of Molecular Sciences 2020; 21(24): 9473 doi: 10.3390/ijms21249473
|
3 |
Thomas Ward, Samantha Webster, Sari Mishina, Phil McEwan, Gail Wygant, Feng Wang. Assessing the Budget Impact and Economic Outcomes of the Introduction of Daclatasvir + Asunaprevir and Sofosbuvir/Ledipasvir for the Treatment of Chronic Hepatitis C Virus Infection in Japan. Value in Health Regional Issues 2017; 12: 1 doi: 10.1016/j.vhri.2016.10.002
|
4 |
Tatsuo Kanda, Kazushige Nirei, Naoki Matsumoto, Teruhisa Higuchi, Hitomi Nakamura, Hiroaki Yamagami, Shunichi Matsuoka, Mitsuhiko Moriyama. Retreatment of patients with treatment failure of direct-acting antivirals: Focus on hepatitis C virus genotype 1b. World Journal of Gastroenterology 2017; 23(46): 8120-8127 doi: 10.3748/wjg.v23.i46.8120
|
5 |
Nicholas A. Hummell, Alexey V. Revtovich, Natalia V. Kirienko, Paul Dunman.
Novel Immune Modulators Enhance
Caenorhabditis elegans
Resistance to Multiple Pathogens
. mSphere 2021; 6(1) doi: 10.1128/mSphere.00950-20
|
6 |
Kamil Grubczak, Anna Grzeszczuk, Monika Groth, Anna Hryniewicz, Anna Kretowska-Grunwald, Robert Flisiak, Marcin Moniuszko. Effects of Pegylated Interferon Alpha and Ribavirin (pegIFN-α/RBV) Therapeutic Approach on Regulatory T Cells in HCV-Monoinfected and HCV/HIV-Coinfected Patients. Viruses 2021; 13(8): 1448 doi: 10.3390/v13081448
|
7 |
Saleh A. Alqahtani, Mark S. Sulkowski. HCV: The Journey from Discovery to a Cure. Topics in Medicinal Chemistry 2019; 31: 97 doi: 10.1007/7355_2018_59
|
8 |
Reina Sasaki-Tanaka, Toshikatsu Shibata, Hiroaki Okamoto, Mitsuhiko Moriyama, Tatsuo Kanda. Favipiravir Inhibits Hepatitis A Virus Infection in Human Hepatocytes. International Journal of Molecular Sciences 2022; 23(5): 2631 doi: 10.3390/ijms23052631
|
9 |
Noha G. Bader El Din, Sally Farouk. Exploring the Impact of Different Inflammatory Cytokines on Hepatitis C Virus Infection. Journal of Interferon & Cytokine Research 2024; 44(6): 233 doi: 10.1089/jir.2024.0003
|
10 |
Reina Sasaki, Tatsuo Kanda, Naoya Kato, Osamu Yokosuka, Mitsuhiko Moriyama. Hepatitis C virus-associated hepatocellular carcinoma after sustained virologic response. World Journal of Hepatology 2018; 10(12): 898-906 doi: 10.4254/wjh.v10.i12.898
|